HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The long-acting phosphodiesterase inhibitor tadalafil does not influence athletes' VO2max, aerobic, and anaerobic thresholds in normoxia.

Abstract
Whereas experimental studies showed that in healthy trained subjects, the phosphodiesterase-5 inhibitor (PDE-5i) sildenafil improves exercise capacity in hypoxia and not in normoxia, no studies on the effects of the long half-life PDE-5i tadalafil exist. In order to evaluate whether tadalafil influences functional parameters and performance during a maximal exercise test in normoxia, we studied 14 healthy male athletes in a double-blind cross-over protocol. Each athlete performed two tests on a cycle ergometer, both after placebo or tadalafil (at therapeutic dose: 20 mg) administration. Oxygen consumption (VO2), blood lactate, respiratory exchange ratio, rate of perceived exertion, arterial blood pressure (BP), heart frequency (HR) and oxygen pulse (VO2/HR) were evaluated before exercise, at individual ventilatory and anaerobic thresholds (IVT and IAT), at VO2max and during recovery. Compared to placebo, a single tadalafil administration significantly reduced systolic BP before and after exercise (p < 0.05), decreased VO2/HR at IVT (13.3 +/- 1.8 vs. 14.5 +/- 2.1 mL . beat (-1); p = 0.03), but did not modify individual VO2max, IVT, or IAT. In healthy athletes, 20 mg of tadalafil does not substantially influence physical fitness-related parameters, exercise tolerance, and cardiopulmonary responses to maximal exercise in normoxia; it remains to be verified if higher doses/prolonged use influence health and/or sport performance in field conditions.
AuthorsL Di Luigi, C Baldari, F Pigozzi, G P Emerenziani, M C Gallotta, F Iellamo, E Ciminelli, P Sgrò, F Romanelli, A Lenzi, L Guidetti
JournalInternational journal of sports medicine (Int J Sports Med) Vol. 29 Issue 2 Pg. 110-5 (Feb 2008) ISSN: 0172-4622 [Print] Germany
PMID17614028 (Publication Type: Journal Article)
Chemical References
  • Carbolines
  • Delayed-Action Preparations
  • Phosphodiesterase Inhibitors
  • Placebos
  • Tadalafil
Topics
  • Adult
  • Anaerobic Threshold (drug effects)
  • Carbolines (administration & dosage, pharmacology)
  • Cross-Over Studies
  • Delayed-Action Preparations (pharmacology)
  • Double-Blind Method
  • Exercise Test (methods)
  • Humans
  • Italy
  • Male
  • Oxygen Consumption (drug effects, physiology)
  • Phosphodiesterase Inhibitors (administration & dosage, pharmacology)
  • Physical Endurance
  • Placebos (administration & dosage, pharmacology)
  • Tadalafil

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: